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Phyla nodiflora (Verbenaceae), commonly called frog fruit and locally, jal bhuti, is the traditional folk medicine 
accepted in the Indian Medicine as well as the Traditional system of Chinese Medicine (TCM) for various treatments viz., 
urinary disorder, lithiasis, knee joint pain, diuresis and swelling. In the present study, we tried to standardise crude Phyla 
nodiflora ethanol extract (PNE) using HPTLC and also evaluated its protection against cisplatin induced nephrotoxicity in 
rats. HPTLC quantification of rutin and fingerprinting profile was performed. Serum kidney toxicity markers, renal tissue 
antioxidant and pro-inflammatory cytokine levels were assessed followed by DNA fragmentation assay and 
histopathological examination of renal tissue. Rutin concentration in ethanol extract was found to be 5.35% w/w. In HPTLC 
fingerprinting 12 peaks with Rf ranges from 0.08 to 0.86 were confirmed. Serum biochemical parameters, renal tissue 
antioxidants and pro-inflammatory cytokines levels were found to be restored. The results demonstrated the 
nephroprotective activity of P. nodiflora ethanol extract (400 mg/kg, p.o.) as evidenced by protection of kidneys from 
cisplatin induced DNA fragmentation and damage tissue architecture. 
Keywords: DNA fragmentation assay, Frog fruit, Jal bhuti, Nephroprotective, Rutin 
Cisplatin (cis-diammine dichloroplatinum II, CDDP) 
is platinum-based potent antineoplastic drug used in 
most of the chemotherapy regimens for solid or 
hematologic tumors. Cisplatin forms inter and intra 
stand cross links with DNA of the cell and arrest its 
synthesis and replication in rapidly proliferating 
tumour cells. Cisplatin-DNA crosslinks cause 
cytotoxic lesions in tumour cells and other 
regenerative cells
1
. Among gastro toxicity, 
myelosuppression, ototoxicity and allergic reaction, 
nephrotoxicity is the major dose limiting side effects
2
. 
Approximately, 20% patients under cisplatin 
chemotherapy suffer severely from renal dysfunction 
and one third of patients experience acute renal 
toxicity after few days of initial treatment. The 
mechanism of cisplatin-induced nephrotoxicity 
involves many cellular processes including DNA 
damage, inflammation, oxidative stress and apoptosis. 
Cisplatin preferentially accumulated within the 
proximal tubule cells in the outer medulla of the 
kidney. It lowers the antioxidant enzymes leading to 
enhanced generation of reactive oxygen metabolites 
(ROM) and lipid peroxidation, and thereby plays an 
important role in cisplatin-induced renal cell injury
3
. 
It has been reported that cisplatin induces release of 
proinflammatory cytokines like TNF-α, IL1β and IL6 
by renal epithelial cells. TNF-α causes oxidant stress 
by sensitizing infiltrating leukocytes
4-7
. There is no 
specific medicine for renal toxicity under 
chemotherapy. Only supportive care is provided for 
renal function restoration like hydration with normal 
saline, use of corticosteroids for reduction of 
inflammation or lowering the dose of drug causing 
nephrotoxicity
8
. However, herbal remedy is 
consistently gaining acceptance for the treatment of 
acute renal failure. 
Many Indian medicinal plants are effective against 
acute renal injury
9
. Phyla nodiflora (L.) Greene (Syn. 
Lippia nodiflora Greene or Lippia nodiflora Michx) 
belonging to the Fam. Verbenaceae is the promising 
folk medicinal herb. This herbaceous, low-growing, 
perennial plant creeps on the ground and spreads 
quickly over ground in tropical to warm temperate 
regions of the world
10-12
. In India, it is grown 
commonly in Dindigul, Pudhukottai, Nagapattinam, 
Thoothukudi and Coimbatore districts of Tamil Nadu. 
Traditionally, it is used to treat urinary disorders, 
gonorrhoea, menstrual disorders and respiratory 
diseases. It has been reported to possess 
antispasmodic, antimalarial, analgesic, anti-
inflammatory, antipyretic, diuretic, antimicrobial, 
antidiabetic activity, hepatoprotective, antitumor, 
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. The whole plant extract is reported to 
induce apoptosis and cell cycle arrest in human breast 
cancer cell line, MCF-7
20
. It contains a variety of 
phytoconstituents such as triterpenoids, flavonoids, 
phenols and steroids. Some of the chemical 
constituents which were determined from GC-MS 
analysis were 2,7-dioxatricyclo[4.3.1.0 (3,8)]decan-4-
one, stigmasterol, benzoic acid, 4-etoxy-, ethyl ester, 
azacyclotridecan-2-one and n-hexa-decanoic acid
21
. In 
this study, we made an attempt to carry out 
phytochemical standardisation of the crude ethanol 
extract of Phyla nodiflora using HPTLC, and also 
explored its nephroprotective activity against the 
cisplatin-induced renal damage in rats.  
 
Materials and Methods 
 
Plant authentication and Extraction procedure 
Whole plant of Phyla nodiflora was collected  
from Dindigul, Tamil Nadu and authenticated by  
Prof. NK Dubey, Department of Botany (Banaras 
Hindu University), Varanasi. The voucher specimen 
(Cog/PN/2014-15) was deposited in the Department 
of Pharmaceutics, Indian Institute of Technology 
(Banaras Hindu University), Varanasi (UP) for future 
references. The fresh plants were cleaned by washing 
in running tap water then dried under shade for seven 
days. Dried plants were coarsely powdered using a 
mechanical grinder and sieve no. 60. About 500 g of 
coarsely powdered drug was exhaustively extracted in 
a soxhlet extractor using 95% ethanol for three days. 
The extract obtained was concentrated using vacuum 
rotary evaporator (IKA RV 10, China) to yield the 
crude Phyla nodiflora ethanol extract (PNE). 
 
Phytochemical evaluation  
The dried crude extract was qualitatively 
standardised by preliminary phytochemical screening 
to detect the presence of various phytochemical 
classes. The total of phenolic content, tannin content, 
flavonoids, and flavonols was done by spectro-
photometric quantification method and all the results 




High performance thin layer chromatography analysis  
Rutin was purchased from Natural remedies Pvt. 
Ltd. Bengaluru. Merk 60F254 (E. Merck) silica plates 
of uniform thickness of 0.2 mm were used for plate 
development. The analysis was done by using 
Camag–HPTLC instrumentation equipped with Lino-
mat V sample applicator and WINCATS 4 software 
for data interpretation, Camag TLC scanner 3, Camag 
TLC visualizer. The Rf values were recorded and the 
developed plate was analyzed and photodocumented 
at ultraviolet range with wavelength (λmax) of 254 nm. 
Sample was prepared in methanol at different 
concentration. PNE was chemically standardized by 
using rutin (flavonoid glycoside) as standard, using 
solvent system ethyl acetate: formic acid: acetic acid: 
water (20:2.2:2.2:1.1) as solvent system. The HPTLC 
fingerprinting was done using mobile phase toluene: 
ethyl acetate: formic acid (10:3:1).  
 
Experimental animals  
The certified pathogen free healthy Charles Foster 
albino male rats (150-250 g) were procured from the 
Central Animal House (Reg. No. 542/02/ab/CPCSEA), 
Institute of Medical Sciences (Banaras Hindu 
University), Varanasi, India. Animals were housed in 
polypropylene cages and maintained under standard 
conditions (12 h light and dark cycles at an ambient 
temperature of 25 C and 45-55% RH). The animals 
were allowed to acclimatize to the environment for 7 
days before the commencement of experiments. They 
were fed with commercially available standard rat 
feed and water ad libitum. All experimental protocols 
were approved from Central Animal Ethical 
Committee of Banaras Hindu University (No. Dean/2015/ 
CAEC/1132) and were conducted in accordance with 
accepted standard guidelines of National Institutes of 
Health Guide for Care and Use of Laboratory 
Animals (Publication no. 85–23, revised 1985). 
 
Optimisation of cisplatin dose to induce nephrotoxicity 
To evaluate the dose of cisplatin which induce 
nephrotoxicity, rats were randomly divided into three 
groups with six animals each. Cisplatin (Cytoplatin-
10, cipla), was given at different dose of 4 mg/kg, i.p., 
6 mg/kg, i.p., and 8 mg/kg i.p., after 72 h of cisplatin 
administration blood was collected through retro-
orbital venous plexus under light anaesthesia then serum 
was separated and tested for urea and creatinine level. 
Serum urea kit and creatinine kit were purchased from 
Erba Diagnostics Mannheim, Germany. 
 
Experimental setup and drug treatment protocol 
In order to evaluate the effect of PNE on cisplatin 
induced nephrotoxicity, rats were randomly divided 
into five groups with six animals in each. The 
treatment details of groups were as follows: Group I 
(Normal control): vehicle (aqueous solution of 0.5% 
CMC) for 7 consecutive days and 0.9% NaCl on 4
th
 
day; Group II (Toxic control): vehicle (aqueous 
solution of 0.5% CMC) for 7 consecutive days and 




cisplatin (6 mg/kg, i.p.) on 4
th
 day; and Groups III-V: 
PNE (@100, 200 and 400 mg/kg, p.o.) for  
7 consecutive days and cisplatin (6 mg/kg, i.p.) on 4
th
 
day, respectively. The PNE extract was suspended in 
0.5% CMC and given orally. PNE and vehicle were 
given orally for total 7 days, cisplatin (6 mg/kg, i.p.) 
freshly prepared in normal saline (0.9% NaCl) was 
administered to respective rats on 4
th
 day of the 
treatment. Finally on 7
th
 day, animals were sacrificed 
to collect blood and kidney for various biochemical 
tests, antioxidant parameters, estimation of pro-
inflammatory cytokines level and histological studies.  
 
Biochemical parameters in serum 
Serum urea and serum creatinine level were 
measured by autoanalyzer using BUN method and 
modified rate Jaffe’s kinetic method. Serum glutamic 
oxaloacetic transaminase (SGOT), serum glutamic 
pyruvic transaminase (SGPT), total protein, total 
bilirubin and direct bilirubin and alkaline phosphate 
(ALP)
 
level were analysed according to standard 
protocol given in enzyme assay kit (Span diagnostic 




Antioxidant parameters in kidney tissue homogenate 
Minced kidney tissues were homogenized in 0.1 M 
potassium phosphate buffer (pH 7) in a tissue 
homogenizer containing protease inhibitor to get 10% 
homogenate (w/v), which was centrifuged at 10000×g, 
for 20 min at 4ºC. The supernatant was utilized for 
antioxidant status. Lipid peroxidation (LPO) levels 
were determined in terms of thiobarbituric acid 
reacting substance (TBARS) and expressed as 
equivalent to malondialdehyde (MDA) using 1 1   -
tetramethoxypropane as standard malondialdehyde 
(MDA). Superoxide dismutase (SOD) was estimated 
in terms of its capacity to inhibit the reduction of nitro 
blue tetrazolium (NBT) by superoxide, generated in 
the presence of riboflavin in reaction system through 
a photosensitive reaction. Catalase (CAT) activity was 
expressed from the rate of decomposition of H2O2 at 
240 nm following the addition of tissue homogenate. 
Reduced glutathione (GSH) level was calculated as 
protein-free sulfhydryl content using 5,5-dithiobis-2-
nitrobenzoic acid (DTNB). 
 
Proinflammatory cytokines in kidney tissue homogenate 
The proinflammatory molecules generated by 
cisplatin induced nephrotoxicity were investigated by 
measuring cytokine levels of TNF-α, IL-6 and IL-1β 
on homogenised kidney tissues using ELISA kits for 
determination of interleukin-1β, interleukin-6, TNF-α 
(Komabiotech, Korea). Given standard and detection 
antibodies needed to be reconstituted in sterile water. 
Standard and samples were diluted in serial dilution. 
Wells were selected in microplate and washed with 
washing solution then 100 mL of standard and 
samples were added to wells followed by addition of 
diluted detection antibody after incubation. Colour 
was developed after addition of colour development 
enzyme and colour development solution. Finally, 
absorbance was measured by microplate reader 
(BioTek instruments Inc. USA).  
 
DNA fragmentation assay by agarose gel electrophoresis 
Kidneys were harvested and washed with sterile 
water and cut into small pieces using sterile surgical 
blade followed with homogenisation in PBS buffer. 
Homogenate was centrifuged for three times to 
remove cell debris and RBCs at 3000 rpm for 10 min 
at 4°C, and the supernatant was discarded. The pellet 
of cells was washed twice with PBS and lysed in a 
buffer containing 50 mmol/L Tris–HCl pH 8.0 and 
0.5% SDS, and incubated at 37°C for 30 min then 
mixed uniformly. The pellet was incubated with  
1.0 μL of DNAase free RNase (10 mg/mL) for 1 h at 
 7°C. Further, proteinase K (50 μg/mL) was added 
and incubated for 90 min at 50°C. The precipitated 
DNA was dissolved in a 5 μL of Tris-EDTA buffer 
and quantified spectrophotometrically. An equal 
concentration of DNA (10 μg) stained with ethidium 
bromide had been resolved on a 1% agarose gel at  
50 V for 4 h, viewed under UV light, and documented 




Kidneys were dissected out and after washing with 
isotonic saline were fixed in 10% neutral buffered 
formalin for 48 h and embedded in paraffin wax. 
Paraffin blocks of the tissues were sectioned (5-6 µm 
thickness) by microtome then stained with 
Hematoxylin and Eosin (H&E) and subjected to the 
microscopic and imaging system (Nikon, Japan). 
 
Statistical analysis 
The experimental data are expressed as mean ± 
S.E.M., with six animals in each group. The analysis 
of variance was performed with Graph pad Prism 5.0 
software (Graph Pad Software, Inc., La Jolla, CA) 
followed by one-way ANOVA. Dunnett’s Comparison 
test was applied for determining the statistical 
significance between different groups. 
 






Phytochemical evaluation  
The yield of PNE was found to be 16.6% w/w of 
air dried plant material. The qualitative phytochemical 
screening of PNE showed the presence of alkaloids, 
flavonoids, phenolics, phytosterols, tannins, saponins 
and glycosides. Total flavonoids and flavonols 
content measurement was done triplicate and was 
found to be 7.63 mg/g and 3.45 mg/g (rutin equivalent 
per gram plant material), respectively. The total 
phenolic content and total tannin content in PNE was 
found to be 56.15 mg/g and 34.21 mg/g (tannic acid 
equivalent per gram plant material), respectively. 
 
High performance thin layer chromatography analysis 
HPTLC results for quantification of rutin and 
finger printing was performed at scanning wavelength 
at 254 nm and chromatogram were obtained. The 
peak of rutin was identified and compared by 
comparing their retention factor (Rf) values with that 
of standards rutin. The quantity of rutin was found to 
be 5.35% w/w. The study revealed that solvent system 
toluene:ethyl acetate:formic acid (10:3:1) showed 
maximum number of peaks in the range of Rf value 
0.08 to 0.86 at wavelength 254 nm (Fig. 1). The 
chromatogram suggested that out of 12 compounds 
the compounds with Rf value 0.22 and 0.37 were 
predominant as they had a maximum percentage area 
with 45.73% and 14.89%. Phytoconstituents with 
their Rf values, peak height and area are given in 
(Table 1).  
 
Optimisation of cisplatin dose to induce nephrotoxicity 
Rats administered with 4 mg/kg i.p. of cisplatin 
showed no significant elevation (P >0.05) in serum 
urea and creatinine concentration after 72 h of 
cisplatin administration. 6 and 8 mg/kg, i.p. of 
cisplatin showed marked elevation (P <0.05) in serum 
urea and creatinine concentration in rats. At 8 mg/kg, 
i.p. of cisplatin two rats out of six died. Therefore, to 
evaluate nephroprotective activity of PNE, 6 mg/kg, 
i.p of cisplatin was used for further induction of 
nephrotoxicity in rats (Fig. 2).  
 
Effect of PNE on serum biochemical parameters  
Renal toxicity was induced by cisplatin (6 mg/kg, 
i.p.) followed by treatment with PNE at different 
doses. PNE (400 mg/kg, p.o.) for seven days 
significantly decreases (P <0.05) the elevated levels 
of biochemical parameters to normal as compared to 
control group. PNE (100 and 200 mg/kg, p.o.) did not 
show significant protection (P >0.05) (Table 2). 
 
Table 1 — HPTLC finger printing profile of PNE showing various peaks 
Peak Start Rf  Max Rf  End Rf  Start height Max height  End height Area Area %  
1 0.08 0.10 0.12 1.0 23.8 2.1 369.7 1.50 
2 0.16 0.18 0.19 1.2 16.7 1.1 210.6 0.86 
3 0.22 0.30 0.37 8.7 340.5 38.0 11261.4 45.73 
4 0.37 0.41 0.43 39.4 144.6 87.5 3666.6 14.89 
5 0.43 0.44 0.49 87.8 95.7 10.9 1973.2 8.01 
6 0.50 0.51 0.53 8.5 12.1 1.1 152.5 0.62 
7 0.55 0.59 0.61 3.5 24.2 6.2 482.9 1.96 
8 0.61 0.62 0.64 6.8 28.4 18.1 467.8 1.90 
9 0.64 0.67 0.70 18.2 85.3 19.8 2129.1 8.65 
10 0.71 0.75 0.76 21.1 94.7 78.6 2045.3 8.31 
11 0.76 0.77 0.81 79.8 87.8 9.6 1597.2 6.49 
12 0.86 0.88 0.91 10.4 23.9 0.2 270.4 1.10 
 
 
Fig. 1 — HPTLC chromatogram of (A) PNE showing peak of 
rutin; (B) standard rutin; and (C) HPTLC fingerprinting profile  
of PNE 




Effect of PNE on antioxidant status in renal tissues of rats 
The activity of SOD, Catalase and GSH content 
was significantly decreased while MDA level was 
significantly increased in cisplatin (6 mg/kg, i.p.) 
treated rats as compared to control group. PNE  
(400 mg/kg, p.o.) treatment significantly inverted the 
changes in antioxidant enzymes in dose dependent 
manner (P <0.05). Treatment with PNE significantly 
normalised the levels of catalase, GSH and MDA 
level (Table 2). 
 
Effect of PNE on proinflammatory cytokines in renal tissue of 
rats 
By measuring cytokine levels of TNF-α, IL-6 and 
IL-1β on homogenised kidney tissues using standards. 
It was evaluated that there was production of 
proinflammatory molecules in renal tissue 
homogenate, due to inflammation caused by cisplatin. 
However, PNE treated rats (400 mg/kg, p.o.) reduced 
expression of these proinflammatory molecules in the 
kidney tissues (Table 2). 
 
DNA fragmentation assay by agarose gel electrophoresis 
From the figure it can be observed that cisplatin 
treatment result in a substantial increase in 
oligonucleosome-length degradation of DNA. 
However, the PNE (400 mg/kg, p.o.) treatment 
significantly inhibited this smear length and there was 
approximately no smearing occurred, it showed 
significant protection of DNA damage (Fig. 3). 
 
Table 2 — Effect of various doses of ethanol extract of Phyla nodiflora on various parameters in cisplatin treated nephrotoxic rats 
Parameters Unit Treatment groups  
  Control Toxic control PNE 100 mg/kg PNE 200 mg/kg PNE 400 mg/kg Rutin 
Biochemical analysis in blood serum  
Urea  (mg/dL) 46.8±0.09 71.9±2.17*** 66.05±2.61*** 59.51±2.24** 48.71±2.6  50.48±2.24 
Creatinine  (mg/dL) 0.39±0.004 0.57±0.05* 0.56±0.03* 0.47±0.04 0.39±0.05  0.46±0.04 
SGOT  (IU/L) 137.14±0.67 170.06±3.4*** 163.48±5.7** 159.33±4.3** 143.17±6.16  149.5±4.3** 
SGPT  (IU/L) 65±4.9 88.05±3.4*** 84.41±2.4** 78.7±4.19 63.55±3.6  69.85±4.3 
TP  (g/dL) 7.4±0.4 5.95±0.28 5.9±0.68 6.67±0.23 6.95±0.46  7.09±0.33 
TB (mg/dL) 1.24±0.22 4.4±0.37*** 4.3±0.26*** 2.6±0.46* 1.6±0.50  3.01±0.45** 
DB  (mg/dL) 0.41±0.04 1.04±0.012** 0.81±0.15 0.76±0.15 0.55±0.14  0.57±0.15 
ALP  (IU/L) 68.4±3.1 258.4±13.9*** 254.2±10.1*** 152.8±6.09*** 77.8±6.5  80.16±4.6* 
Antioxidant enzymes  
CAT (g/mg of protein)  28.45±0.8 12.03±1*** 15.09±0.76*** 20.88±0.82*** 26.96±0.69 25.93±0.55* 
LPO (nmol MDA/g of 
tissue)  
24.58±2.34  61.93±7.9***  59.18±6.23*** 32.35±2.25 21.83±3.4 26.32±8.12 
SOD (Units/mg protein)  36.38±0.33 14.53±2.34*** 22.35±0.84*** 23.69±0.77*** 36.42±0.59 33.12±1.94 
GSH (μg glutathione per 
mg protein) 
264.2±2.64  122.2±8.4* 139.3±7.49* 199.15±12.0 259.28±6.3 250.14±8.24 
Proinflammatory cytokines 
IL-1β  (pg/mL) 483.7±5.2 1211.78±3.4***  1016.78±5.5***  877.05±6.8***  519.76±15.45*  548.73±9.4*** 
IL-6  (pg/mL) 723.42±8.17 1271.75±12.33*** 1285.083±13.5*** 1069.25±9.6*** 746.75±10.38 780.08±15.7** 
TNF-α (pg/mL) 169.7±3.2 857.3±3.9*** 821.2±2.9*** 647.1±10.1*** 231.2±24.9** 238.59±22.89** 
[Values are mean ± SEM, (n=6). One way ANOVA followed by Dunnett’s test, Note: n=6 in each group *P value <0.05, **P value 
<0.01, ***P value <0.001] 
 
 
Fig. 2 — Serum Urea and Creatinine concentration at different 
doses of cisplatin 





Renal sections of control group (Gr. I) showed 
normal histology. Kidneys of cisplatin treated rats 
(Gr. II) were found to have distorted histology with 
atrophied glomerulus, extensive loss of tubular 
epithelial cells, tubular dilation, collecting tubules 
showing necrosis, intra-tubular debris and cast 
formation and vacuolization. The treatment group 
with 100 mg/kg dose of PNE (Gr. IIIA) showed 
altered histology with no protective effect whereas 
The treated group with 200 mg/kg dose of PNE  
(Gr. IIIB) showed damaged histology with less 
protective effect but treatment group with 400 mg/kg 
dose of PNE (Gr. IIIC) showed protective action by 
reducing inflammation, minimizing necrosis and 
vacuolization (Fig. 4). 
 
Discussion 
Kidneys help in maintaining the homeostatic 
balance of body fluids by filtering and secreting toxic 
metabolites from the blood. They have vital role in 
controlling blood pressure, erythropoiesis and glucose 
metabolism. Therefore, to conserve the kidney 
functions from various toxic agents is foremost. 
Cisplatin is a potent platinum based anticancer drug. 
Its major dose limiting side effect is nephrotoxicity, as 
it accumulates five times more in tubular epithelial 
cells in comparison to serum. It also causes 
impairment in liver function and marked elevation in 
hepatic enzyme.
 
Its mechanism of nephrotoxicity is 
different from killing tumour cells. The accumulation 
of cisplatin is highest in S3 segment of PCT of the 
inner cortex and outer medulla and it is taken up to 
PCT of nephron through the organic cation transporter 
(OCT 2) and also through passive diffusion. 
 
Pathogenic events involved in nephrotoxicity are 
mainly cellular oxidative damage by free radicals and 
production of various proinflammatory cytokines 






Fig. 3 — Agarose gel electrophoresis of cisplatin and PNE treated 
rats. [Lane 1: PNE 400 mg/kg, p.o., Lane 2: PNE 200 mg/kg, p.o., 
Lane 3: PNE 100 mg/kg, p.o., Lane 4: cisplatin 6 mg/kg, i.p., 
Lane 5: control. Each lane reflecting the presence of DNA 
fragments was viewed on an ethidium bromide‑stained gel] 
 
 
Fig. 4 — Tissue architecture of rat kidney showing the effect of PNE at different doses in cisplatin induced tubular damage. [Gr. I: 
control, Gr. II: Toxic control group, Gr. IIIA: Treatment group with 100 mg/kg, per oral of PNE, Gr. IIIB: Treatment group with 200 
mg/kg, per oral of PNE, Gr. IIIC: Treatment group with 400 mg/kg, per oral of PNE] 




In the present study, Phyla nodiflora extract (PNE) 
was chemically standardized with rutin using HPTLC. 
The flavonoid rutin was taken as the standard for 
further experiments as it is been reported to have anti-
inflammatory, antioxidant and nephroprotective 
properties
29-31
. The dose standardisation of cisplatin 
(by taking different doses) evaluated that at a single 
dose of cisplatin (6 mg/kg, i.p.), produces 
nephrotoxicity after 72 h of administration. It was 
evidenced from elevated level of serum urea, 
creatinine and other biochemical parameters. Study 
found that of PNE (400 mg/kg, p.o.) lowers the 
cisplatin induced raised levels of biochemical markers 
and also restore the antioxidant enzymes like GSH, 
CAT and SOD which might be due to excessive 
accumulation ROS by cisplatin. As LPO is an 
autocatalytic process, the LPO assay is the convenient 
method to measure oxidative damage to tissues, hence 
we did. MDA is one of the end products in the lipid 
peroxidation process and releases during oxidative 
degeneration as a product of free oxygen radicals, 
which can be calculated as an indicator of lipid 
peroxidation. It was found that MDA production was 
significantly reduced by treatment of PNE.  
Inflammation is a major consequence in various 
pathological conditions. The role of inflammation in 
nephrotoxicity is highly acknowledged with the 
participation of proinflammatory cytokines, 
chemokines, leukocytes and adhesion molecules.
 
TNF-α is an intercellular chemical messenger and is 
involved in the inflammatory process released by  
T lymphocytes, white blood cells, macrophages and 
monocytes. In infection, sepsis, and ischemia IL-1β 
has been reported to be a proximal mediator of the 
inflammatory events. IL‐6 (polypeptide) secreted 
from activated macrophages, monocytes, adipocytes, 
endothelial cells and fibroblasts in response to various 
stimuli, such as TNF‐α, IL‐1β, bacterial endotoxins, 
physical exercise and oxidative stress. In our study, it 
is demonstrated that there was significant increase in 
IL-1β, IL-6 and TNF-α in kidney tissues of rats 
treated with cisplatin. Cytokines IL-6, IL-1β and 
TNF-α orchestrate the inflammatory response. PNE 
also prevented oxidative DNA damage in renal tissues 
in cisplatin treated rats. Normal histological feature 
indicated in transverse section of kidney tissue was 
also get impaired including swelling, vacuolization, 
proximal tubular necrosis, glomerular congestion and 
inflammation by single dose of cisplatin. Damaged 
tissue architecture by cisplatin brought to normal by 
PNE treatment at dose of 400 mg/kg, p.o. It is 
justified from the present study that PNE  
(400 mg/kg, p.o.) has protective effect by resisting 
cisplatin induced nephrotoxicity. The mechanism by 
which PNE attenuates cisplatin induced 
nephrotoxicity is suggested to be via depreciation of 
free radical oxidative stress and proinflammatory 
cytokines levels.  
 
Conclusion 
The observed results of treatments with the crude 
ethanolic exttact of Phyla nodiflora, describe 
mechanism to attenuate cisplatin induced 
nephrotoxicity by reducing the oxidative stress and 
inflammatory markers predominantly IL-1β, IL-6 and 
TNF-α. It also protected cisplatin administered 
kidneys from DNA fragmentation and altered tissue 
architecture. The results suggest that the jal bhuti, 
Phyla nodiflora could be considered as a new source 
of rutin and also demonostrated its protective effect 
against cisplatin mediated tubular damage. 
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